Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
The University of California, Los Angeles (UCLA), Los Angeles, California The Ohio State University, Columbus, Ohio The Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania